BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Context Therapeutics Inc. (NASDAQ:CNTX)

4 posts

Biotech NewsYou Need to Invest in Context Therapeutics (CNTX) Before It’s Too Late

  • BioTech Health X
  • March 29, 2026
We recently published our article Top 10 Trending Micro-Cap Biotech Stocks to Watch Today. In this piece, we…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Trending Micro-Cap Biotech Stocks to Watch Today

  • BioTech Health X
  • March 27, 2026
In this article, will take a look at the Top 10 Trending Micro-Cap Biotech Stocks to Watch Today.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsContext (CNTX)’s Glow-Up: From “Old Thesis” to T-Cell Engager Chaos (In a Good Way)

  • BioTech Health X
  • February 13, 2026
We recently published our article Top 10 Cancer Biotech Small-Caps That Could Shock the Market Next. This piece…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 10 Cancer Biotech Small-Caps That Could Shock the Market Next

  • BioTech Health X
  • February 13, 2026
In this article, we will take a look at the Top 10 Cancer Biotech Small-Caps That Could Shock…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
  • Would You Still Dare to Invest in Revolution Medicines (RVMD)?
  • Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
  • AbbVie (ABBV) Delivers $17.4 Billion in Revenue
  • Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
Featured Posts
    • November 6, 2026
    Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
    • November 6, 2026
    Would You Still Dare to Invest in Revolution Medicines (RVMD)?
    • November 6, 2026
    Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
    • November 6, 2026
    AbbVie (ABBV) Delivers $17.4 Billion in Revenue
    • November 6, 2026
    Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
Recent Posts
  • Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
    • November 6, 2026
  • Natera (NTRA) Gets a Growth Spurt as Cancer Testing Volume Jumps 57%
    • November 6, 2026
  • Is it Still a Wise Move to Invest in Cogent Biosciences (COGT)?
    • November 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (6)
  • Biotech News (1,185)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top